Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Phio Pharmaceuticals Corporation | PHIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.39 | 3.96% | 10.25 | 10.24 | 9.50 | 9.51 | 9.86 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 9.01 | 11.50 | 2.49 | 21.65% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 536 | 41,692 | $ 9.74 | $ 406,153 | 47,605 | 0.097 - 10.57 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:53:13 | 1 | $ 10.25 | USD |
Phio Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 377.39M | 36.82M | $ -7.36M | -1.20 | 0.60 | 33.29M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Phio Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.219 | 10.57 | 0.179 | 0.3036312 | 3,398,548 | 10.03 | 4,580.37% |
| 1 Month | 0.137 | 10.57 | 0.136 | 0.2337093 | 3,002,508 | 10.11 | 7,381.75% |
| 3 Months | 0.2515 | 10.57 | 0.097 | 0.1941583 | 1,814,675 | 10.00 | 3,975.55% |
| 6 Months | 0.382 | 10.57 | 0.097 | 0.2041858 | 903,218 | 9.87 | 2,583.25% |
| 1 Year | 0.332 | 10.57 | 0.097 | 0.2850429 | 708,153 | 9.92 | 2,987.35% |
| 3 Years | 0.39 | 10.57 | 0.097 | 0.2896207 | 668,073 | 9.86 | 2,528.21% |
| 5 Years | 0.39 | 10.57 | 0.097 | 0.2896207 | 668,073 | 9.86 | 2,528.21% |
Phio Pharmaceuticals Description
| Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immunooncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The clinical development program of the company includes RXI-109, a sd-rxRNA for the treatment of dermal and ocular scarring, and Samcyprone, for the treatment of warts. The pipeline product of the company includes RXI-109, Immuno-oncology cell therapy, samcyprone, RXI-231, and RXI-185. The pipeline programs focus on dermatology, including cosmetic product development, ophthalmology, and cell-based cancer immunotherapy. |
